Letter to the Editor Re: Mohile et al

Affiliations

Comment

Marta Penas-Prado et al. Neuro Oncol. 2020.

. 2020 Jul 7;22(7):1048-1049.

doi: 10.1093/neuonc/noaa109.

¹ Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

No abstract available

Comment on

Urgent Considerations for the Neuro-oncologic Treatment of Patients with Gliomas During the COVID-19 Pandemic.
Mohile NA, Blakeley JO, Gatson NTN, Hottinger AF, Lassman AB, Ney DE, Olar A, Schiff D, Shih HA, Strowd R, van den Bent MJ, Ziu M. Mohile NA, et al. Neuro Oncol. 2020 Apr 11;22(7):912-7. doi: 10.1093/neuonc/noaa090. Online ahead of print. Neuro Oncol. 2020. PMID: 32277236 Free PMC article.

1. Liang W, Guan W, Chen R, et al. . Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–337. - PMC - PubMed
1. Penas-Prado M, Armstrong TS, Gilbert MR. Progress in rare central nervous system tumors. Curr Opin Neurol. 2019;32(6):895–906. - PubMed
1. Rudà R, Reifenberger G, Frappaz D, et al. . EANO guidelines for the diagnosis and treatment of ependymal tumors. Neuro Oncol. 2018;20(4):445–456. - PMC - PubMed
1. Franceschi E, Hofer S, Brandes AA, et al. . EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. Lancet Oncol. 2019;20(12):e715–e728. - PubMed
1. Mansouri A, Zadeh G. NCI-CONNECT rare CNS tumor initiative: current progress and anticipated future impact. Neuro-Oncol. Adv. 2020; 2(1). - PMC - PubMed